Antibodies and Fc fusion proteins with altered immunogenicity

Details for Australian Patent Application No. 2006204791 (hide)

Owner Xencor, Inc.

Inventors Moore, Gregory L.; Marshall, Shannon Alicia

Agent Davies Collison Cave

Pub. Number AU-A-2006204791

PCT Pub. Number WO2006/076594

Priority 60/652,958 14.02.05 US; 60/654,636 17.02.05 US; 60/643,313 12.01.05 US

Filing date 12 January 2006

Wipo publication date 20 July 2006

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076594 Priority application(s): WO2006/076594

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204792-Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

2006204790-1,3-diaryl substituted ureas as modulators of kinase activity